Dr. Fan Liang, is the medical director of the Johns Hopkins Center for Transgender and Gender Expansive Health in Baltimore, Maryland
The move comes days after a Federal judge issued a ruling that stayed the FDA's 2000 approval of the abortion medication mifepristone
